Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02523222 · ClinicalTrials.gov registry record · Phase 2
Dextrose Gel Does Not Prevent Neonatal Hypoglycemia
A Phase 2 study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 236
- Enrollment target
NCT02523222 is a Phase 2 study that has completed, run by Baylor College of Medicine. The registered enrollment target is 236 participants.
The verdict
NCT02523222, a Phase 2 study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 236 participants
- Enrollment target
Study Summary
This was a quasi-experimental pilot study comparing blood glucose values 30 minutes after feeding alone or feeding + dextrose gel in newborns at risk for transient neonatal hypoglycemia.
Interventions
- DIETARY_SUPPLEMENT 40% Dextrose gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 236 participants |
| Start Date | 2016-07-01 |
| Est. Completion | 2018-07-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02523222
The ClinicalTrials.gov registry entry for NCT02523222 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 236 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 40% Dextrose gel is the first listed.
NCT02523222 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02523222 about?
NCT02523222 is a clinical study titled "Dextrose Gel Does Not Prevent Neonatal Hypoglycemia". This was a quasi-experimental pilot study comparing blood glucose values 30 minutes after feeding alone or feeding + dextrose gel in newborns at risk for transient neonatal hypoglycemia.
What is the current status of trial NCT02523222?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 236 participants. The study started on 2016-07-01. Estimated completion is 2018-07-30.
What interventions are being tested in trial NCT02523222?
The interventions under investigation include: 40% Dextrose gel (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02523222?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.